These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
365 related articles for article (PubMed ID: 8631663)
41. Production and purification of the bacterial autolysin N-acetylmuramoyl-L-alanine amidase B from Pseudomonas aeruginosa. Scheurwater EM; Pfeffer JM; Clarke AJ Protein Expr Purif; 2007 Nov; 56(1):128-37. PubMed ID: 17723308 [TBL] [Abstract][Full Text] [Related]
42. ["In vitro" activity of gentamicin, sisomicin and tobramycin against "pseudomonas aeruginosa" strains from hospital sources (author's transl)]. Campello C; Crevatin E Ann Sclavo; 1977; 19(3):437-45. PubMed ID: 415672 [TBL] [Abstract][Full Text] [Related]
43. Induction of autolysis in Enterococcus faecalis S-47 by peptide AS-48. Gálvez A; Valdivia E; Martínez-Bueno M; Maqueda M J Appl Bacteriol; 1990 Sep; 69(3):406-13. PubMed ID: 1700974 [TBL] [Abstract][Full Text] [Related]
44. [Susceptibility of Pseudomonas aeruginosa to aztreonam in comparison to other pseudomonas-active beta-lactam antibiotics and gentamicin]. Wundt W; Lange KP; Baumgärtner M Arzneimittelforschung; 1985; 35(8):1322-5. PubMed ID: 3935123 [TBL] [Abstract][Full Text] [Related]
45. The antibacterial activity of E. coli bacteriophage lysin lysep3 is enhanced by fusing the Bacillus amyloliquefaciens bacteriophage endolysin binding domain D8 to the C-terminal region. Wang S; Gu J; Lv M; Guo Z; Yan G; Yu L; Du C; Feng X; Han W; Sun C; Lei L J Microbiol; 2017 May; 55(5):403-408. PubMed ID: 28124780 [TBL] [Abstract][Full Text] [Related]
46. Antibiotics Stimulate Formation of Vesicles in Andreoni F; Toyofuku M; Menzi C; Kalawong R; Mairpady Shambat S; François P; Zinkernagel AS; Eberl L Antimicrob Agents Chemother; 2019 Feb; 63(2):. PubMed ID: 30509943 [TBL] [Abstract][Full Text] [Related]
47. Synergistic killing of Streptococcus pneumoniae with the bacteriophage lytic enzyme Cpl-1 and penicillin or gentamicin depends on the level of penicillin resistance. Djurkovic S; Loeffler JM; Fischetti VA Antimicrob Agents Chemother; 2005 Mar; 49(3):1225-8. PubMed ID: 15728935 [TBL] [Abstract][Full Text] [Related]
48. Tobramycin, amikacin, sissomicin, and gentamicin resistant Gram-negative rods. Drasar FA; Farrell W; Maskell J; Williams JD Br Med J; 1976 Nov; 2(6047):1284-7. PubMed ID: 1000196 [TBL] [Abstract][Full Text] [Related]
50. Mechanism of phenotypic tolerance of nongrowing pneumococci to beta-lactam antibiotics. Tuomanen E; Tomasz A Scand J Infect Dis Suppl; 1990; 74():102-12. PubMed ID: 1982975 [TBL] [Abstract][Full Text] [Related]
51. Discovery of novel S. aureus autolysins and molecular engineering to enhance bacteriolytic activity. Osipovitch DC; Therrien S; Griswold KE Appl Microbiol Biotechnol; 2015 Aug; 99(15):6315-26. PubMed ID: 25690309 [TBL] [Abstract][Full Text] [Related]
52. Specificity of a bacteriolytic enzyme from Pseudomonas aeruginosa. Lache M; Hearn WR; Zyskind JW; Tipper DJ; Strominger JL J Bacteriol; 1969 Oct; 100(1):254-9. PubMed ID: 4981057 [TBL] [Abstract][Full Text] [Related]
53. Interaction of methylxanthines and gentamicin against Staphylococcus aureus and Pseudomonas aeruginosa: role of phosphodiesterase inhibition. Bazzaz BS; Lavaei S; Hosseinzadeh H Acta Microbiol Immunol Hung; 2012 Mar; 59(1):13-20. PubMed ID: 22510283 [TBL] [Abstract][Full Text] [Related]
54. In vitro activity of gentamicin, vancomycin or amikacin combined with EDTA or l-arginine as lock therapy against a wide spectrum of biofilm-forming clinical strains isolated from catheter-related infections. Lebeaux D; Leflon-Guibout V; Ghigo JM; Beloin C J Antimicrob Chemother; 2015; 70(6):1704-12. PubMed ID: 25712314 [TBL] [Abstract][Full Text] [Related]
55. Co-encapsulation of gallium with gentamicin in liposomes enhances antimicrobial activity of gentamicin against Pseudomonas aeruginosa. Halwani M; Yebio B; Suntres ZE; Alipour M; Azghani AO; Omri A J Antimicrob Chemother; 2008 Dec; 62(6):1291-7. PubMed ID: 18931388 [TBL] [Abstract][Full Text] [Related]
56. Transfer of plasmid-mediated antibiotic resistance in strains of Pseudomonas aeruginosa isolated in Auckland. Bremner DA J Med Microbiol; 1979 Aug; 12(3):303-10. PubMed ID: 112254 [TBL] [Abstract][Full Text] [Related]
57. Application of X-ray micrography and imaging to study the effect of gentamicin on Pseudomonas aeruginosa. Rajyaguru JM; Torres DS; Abel E; Richardson MC; Muszynski MJ J Antimicrob Chemother; 1998 May; 41(5):557-61. PubMed ID: 9630409 [TBL] [Abstract][Full Text] [Related]
58. Antibacterial activity of chensinin-1b, a peptide with a random coil conformation, against multiple-drug-resistant Pseudomonas aeruginosa. Shang D; Meng X; Zhang D; Kou Z Biochem Pharmacol; 2017 Nov; 143():65-78. PubMed ID: 28756209 [TBL] [Abstract][Full Text] [Related]
59. In vitro activity of fosfomycin-gentamicin, fosfomycin-ceftazidime, fosfomycin-imipenem and ceftazidime-gentamicin combinations against ceftazidime-resistant Pseudomonas aeruginosa. Pruekprasert P; Tunyapanit W Southeast Asian J Trop Med Public Health; 2005 Sep; 36(5):1239-42. PubMed ID: 16438151 [TBL] [Abstract][Full Text] [Related]
60. Contribution of Membrane Vesicle to Reprogramming of Bacterial Membrane Fluidity in Pseudomonas aeruginosa. Mozaheb N; Van Der Smissen P; Opsomer T; Mignolet E; Terrasi R; Paquot A; Larondelle Y; Dehaen W; Muccioli GG; Mingeot-Leclercq MP mSphere; 2022 Jun; 7(3):e0018722. PubMed ID: 35603537 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]